<DOC>
	<DOCNO>NCT00609115</DOCNO>
	<brief_summary>The AMES device design produce functional cortical change : ( 1 ) assist subject he/she attempt move limb ( assisted movement ) ( 2 ) enhance movement sensation vibrate muscle movement ( enhanced sensation ) . The primary hypothesis combination assist movement enhance sensation muscle vibration increase amount motor recovery individual disable stroke .</brief_summary>
	<brief_title>Sub-Acute Stroke Rehabilitation With AMES</brief_title>
	<detailed_description>Approximately 700,000 U.S. citizen stroke year half end significant motor disability . There estimate 5 million stroke survivor U.S. , make stroke lead cause long-term disability U.S.. Existing rehabilitation therapy effective return stroke survivor full motor recovery . The AMES device design able provide therapy ankle joint hand ( fingers/wrist ) . Subjects may qualify one two limb . In 18 treatment session , double-blinded , control study , AMES therapy provide addition usual physician-ordered rehabilitation sub-acute period follow stroke . Those control subject complete Phase 1 placebo session opportunity cross-over participate AMES treatment group Phase 2 .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<criteria>Hemispheric stroke ( ischemic hemorrhagic ) , cortical subcortical , document either CT MRI scan associate residual weakness arm and/or leg . First time ever stroke previous stroke complete resolution motor deficit , occur ≤4 month prior subject enrollment . Age 1880 year old . Moderate severe lowerextremity paresis ( define leg motor FuglMeyer score ≥6 ≤22 possible 34 . Moderate severe upperextremity paresis ( defined arm motor FuglMeyer score ≥6 ≤43 possible 66 . Visible voluntary movement ankle least one direction : dorsiflexion plantarflexion ankle flexion extension hand . At least partially function proprioception paretic arm leg—capable correctly identify , ≥70 % time , direction passive joint rotation ( i.e. , flexionextension ) eye close . Physically cognitively capable consent comply protocol . Score &lt; 19 63 21question version Beck Depression Inventory . Subject legally authorize representative must capable provide informed consent . Complete flaccidity hand , wrist , ankle . Pathological neurological/physical condition , stroke , impair function impair arm leg result pain either arm leg . Spinal cord injury , arthritis , fracture affect limb result loss range motion . Peripheral nerve injury neuropathy result significant motor sensory loss limb consider test . Cardiopulmonary compromise include limit uncontrolled hypertension angina , deep vein thrombosis , decompensated congestive heart failure , myocardial infarction , heart irregularity , exercise intolerance . Major active psychiatric disorder . Severe apraxia ; inability understand verbal ( English ) direction ; inability communicate adequately study personnel . Size arm leg incompatible AMES device . Severe contracture decrease range motion would prohibit comfortable position tolerance device Skin condition able tolerate use AMES device . Any progressive neurodegenerative disorder affect motor system . Uncontrolled seizure disorder . Current abuse alcohol drug . Terminal illness anticipate survival &lt; 12 month . Current plan concurrent participation another study clinical trial . NIH Stroke Scale , follow score : Item 1a &gt; 0 ; Item 1c &gt; 0 ; Item 2 &gt; 0 ; Item 3 &gt; 0 ; Item 9 &gt; 2 ; Item 10 &gt; 1 ; Item 11 &gt; 1 ( base exam Study Physician ) . Intent receive Botox injection , initiation antispasmodic medication , use robotic ( e.g. , MANUS , Locomat ) stimulation device ( e.g. , Bioness ) participate AMES trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Sub-acute care</keyword>
	<keyword>Robotics</keyword>
</DOC>